Literature DB >> 31487495

Poly(ADP-ribose) polymerase-1 inhibits mitochondrial respiration by suppressing PGC-1α activity in neurons.

Ping Lu1, Adam D Hogan-Cann1, Amit Kamboj2, Subir K Roy Chowdhury2, Mohamad-Reza Aghanoori3, Paul Fernyhough3, Christopher M Anderson4.   

Abstract

Poly(ADP-ribose) polymerase-1 (PARP1) is a ubiquitous nuclear enzyme that regulates DNA repair and genomic stability. In oxidative genotoxic conditions, PARP1 activity is enhanced significantly, leading to excessive depletion of nicotinamide adenine dinucleotide (NAD+) and mitochondrial dysfunction. We hypothesized that PARP1-induced NAD+ depletion inhibits NAD+-dependent sirtuin deacetylase activity, thereby interfering with the mitochondrial regulator, peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α). The DNA alkylator, N'-Nitro-N-nitroso-N-methylguanidine (MNNG), induced NAD+ depletion, inhibited sirtuin deacetylase activity and enhanced acetylation of PGC-1α. This was associated with reduced interaction between PGC-1α and nuclear respiratory factor 1 (NRF-1), which is a nuclear transcription factor that drives mitochondrial replication by regulating mitochondrial transcription factor A (TFAM). MNNG also reduced binding of NRF-1 to the tfam upstream promoter region and reduced TFAM mRNA, mitochondrial DNA copy number and respiratory function. MNNG effects were mitigated by PARP1 inhibition and genetic loss of function, by enhancing intracellular NAD+ levels, and with sirtuin (SIRT1) gain of function, supporting a mechanism dependent on PARP1 activity, NAD+-depletion and SIRT1 inhibition. This and other work from our group supports a destructive sequelae of events related to PARP1-induced sirtuin inhibition and sirtuin-mediated regulation of transcription.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  NAD(+); NRF-1; PARP; PGC-1α; SIRT1; TFAM

Mesh:

Substances:

Year:  2019        PMID: 31487495     DOI: 10.1016/j.neuropharm.2019.107755

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  [Effect of mogroside VI on acute liver injury induced by sepsis in mice and related mechanisms].

Authors:  Hai-Yin Zhou; Cai-Xia Long; Lan Luo; Yan-Ying Chen; Ping-Ping Liu; Zheng-Hui Xiao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

2.  NAD+ metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity.

Authors:  Tom Meyer; Dor Shimon; Sawsan Youssef; Gal Yankovitz; Adi Tessler; Tom Chernobylsky; Anat Gaoni-Yogev; Rita Perelroizen; Noga Budick-Harmelin; Lawrence Steinman; Lior Mayo
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

3.  Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.

Authors:  Daniele Tibullo; Cesarina Giallongo; Alessandra Romano; Nunzio Vicario; Alessandro Barbato; Fabrizio Puglisi; Rosalba Parenti; Angela Maria Amorini; Miriam Wissam Saab; Barbara Tavazzi; Renata Mangione; Maria Violetta Brundo; Giacomo Lazzarino; Giuseppe Alberto Palumbo; Giovanni Li Volti; Francesco Di Raimondo; Giuseppe Lazzarino
Journal:  Biomolecules       Date:  2020-04-30

4.  PARP-1 and SIRT-1 are Interacted in Diabetic Nephropathy by Activating AMPK/PGC-1α Signaling Pathway.

Authors:  Hengmei Zhu; Zhi Fang; Jiehui Chen; Yun Yang; Jiacheng Gan; Liang Luo; Xiaojiang Zhan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-25       Impact factor: 3.168

5.  Long-term oral administration of an HNF4α agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function.

Authors:  Vimal Veeriah; Seung-Hee Lee; Fred Levine
Journal:  Cell Death Dis       Date:  2022-01-27       Impact factor: 8.469

Review 6.  Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease.

Authors:  Estefanía de Gregorio; Anna Colell; Albert Morales; Montserrat Marí
Journal:  Int J Mol Sci       Date:  2020-05-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.